Showing results (281-290 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|April 19, 2026
A Seamless Two-Stage Phase I/II Trial Design With Backfill and Joint Monitoring for Dose OptimizationKentaro Takeda, Jing Zhu, Belay B Yimer, et al.Pharmaceutical Statistics|August 10, 2026
Quantitative Dose Optimization for Gene Therapy Trials: Implications for Project Optimus and Early-Phase DesignKevin Roberts, Jeffrey Palmer, Jessica Volpe, et al.Pharmaceutical Statistics|September 24, 2026
Evaluating the Impact of Outcome Delay on the Efficiency of Sample Size Re-EstimationAritra Mukherjee, Michael J Grayling, James M S WasonPharmaceutical Statistics|September 29, 2026
On the Conservativeness of Robust Variance Estimators in Propensity Score Weighted Cox ModelsHiroya Morita, Shunichiro Orihara, Fumitaka Shimizu, et al.Pharmaceutical Statistics|December 20, 2014
The analysis of incontinence episodes and other count data in patients with overactive bladder by Poisson and negative binomial regressionR Martina, R Kay, R van Maanen, et al.Pharmaceutical Statistics|October 15, 2014
Confidence interval estimation for number of patient-years needed to treatHaiyuan Zhu, Xiao WuPharmaceutical Statistics|October 21, 2014
Evaluation of statistical methods for safety signal detection: a simulation studyMaggie Chen, Li Zhu, Padmaja Chiruvolu, et al.Pharmaceutical Statistics|November 6, 2015
Optimal adaptive sequential designs for crossover bioequivalence studiesJialin Xu, Charles Audet, Charles E DiLiberti, et al.Pharmaceutical Statistics|November 6, 2015
Sensitivity analyses for partially observed recurrent event dataMouna Akacha, Emmanuel O OgundimuPharmaceutical Statistics|June 14, 2016
Safety data from randomized controlled trials: applying models for recurrent eventsJohannes Hengelbrock, Johanna Gillhaus, Sebastian Kloss, et al.Pageof 119